1 / 8

R&I: Anthrax Global Clinical Trials Review, H2- Size, Share

GlobalData's clinical trial report, “Anthrax Global Clinical Trials Review, H2, 2014" provides data on the Anthrax clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Anthrax. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. Detailed report at: http://www.reportsandintelligence.com/anthrax-global-clinical-trials-review-h2-2014-market

Jennybeaster111
Download Presentation

R&I: Anthrax Global Clinical Trials Review, H2- Size, Share

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Anthrax Global Clinical Trials Review, H2, 2014 Publisher: Global Data No of pages: 77 Publish Date: Nov 2014

  2. Description GlobalData's clinical trial report, “Anthrax Global Clinical Trials Review, H2, 2014" provides data on the Anthrax clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Anthrax. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Anthrax. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Enquire about report at: http://www.reportsandintelligence.com/enquire-about-report/153542

  3. Scope • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type • Listings of discontinued trials (suspended, withdrawn and terminated) • Get all reports of Pharmaceuticalcategory at: http://www.reportsandintelligence.com/pharmaceuticals-market-report

  4. Reasons to buy • Understand the dynamics of a particular indication in a condensed manner • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more • Obtain discontinued trial listing for trials across the globe • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies • View detailed report at: http://www.reportsandintelligence.com/anthrax-global-clinical-trials-review-h2-2014-market

  5. Table Of Content Table of ContentsTable of Contents 2List of Tables 4List of Figures 5Introduction 6Anthrax 6Report Guidance 6Clinical Trials by Region 7Clinical Trials and Average Enrollment by Country 8Top Countries Contributing to Clinical Trials in Asia-Pacific 10Top Countries Contributing to Clinical Trials in Europe 11Top Countries Contributing to Clinical Trials in North America 12Clinical Trials by G7 Countries: Proportion of Anthrax to Infectious Disease Clinical Trials 13Clinical Trials by Phase in G7 Countries 14Clinical Trials in G7 Countries by Trial Status 15Clinical Trials by E7 Countries: Proportion of Anthrax to Infectious Disease Clinical Trials 16

  6. Table Of Content Unaccomplished Trials of Anthrax 21Subjects Recruited Over a Period of Time 22Clinical Trials by Sponsor Type 23Prominent Sponsors 24Top Companies Participating in Anthrax Therapeutics Clinical Trials 25Prominent Drugs 26Latest Clinical Trials News on Anthrax 27Sep 22, 2014: Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 27Aug 07, 2014: Soligenix Advances Development of a Heat Stable Rapidly Acting Anthrax Vaccine VeloThrax 28Clinical Trial Profiles 30Clinical Trial Overview of Top Companies 30Emergent BioSolutions Inc. 30Clinical Trial Overview of Emergent BioSolutions Inc. 30 PharmAthene, Inc. 31

  7. Table Of Content Clinical Trial Overview of PharmAthene, Inc. 31Elusys Therapeutics, Inc. 32Clinical Trial Overview of Elusys Therapeutics, Inc. 32PaxVax 33Clinical Trial Overview of PaxVax 33Panacea Biotec Limited 34Clinical Trial Overview of Panacea Biotec Limited 34Human Genome Sciences, Inc. (Inactive) 35Clinical Trial Overview of Human Genome Sciences, Inc. (Inactive) 35Green Cross Holdings Corporation 36Clinical Trial Overview of Green Cross Holdings Corporation 36Defence Science and Technology Laboratory 37 Get full TOC at: http://www.reportsandintelligence.com/anthrax-global-clinical-trials-review-h2-2014-market/table-of-contents

  8. FOR MORE DETAILS Visit us at : http://www.reportsandintelligence.com/anthrax-global-clinical-trials-review-h2-2014-market Stay With Us: • TELEPHONE: Direct: +1 (617) 674-4143 • Toll Free: +1 (855) 711-1555E-MAIL: sales@reportsandintelligence.com 5933 NE Win Sivers Drive,#205, Portland, OR 97220United States

More Related